ESI Home Page

Physican Information Patient Information Investor Information Careers at Endocardial Solutions International Information

Annual Report

Latest Quarterly Report

Contact Information

Press Releases

Endocardial Solutions, Inc. (ESI) develops, markets, and distributes an advanced cardiac mapping system for the treatment of patients with rapid or abnormal heart rates. The ¬† 3000ģ System was first introduced to the European market in the second quarter of 1998. In April 1999, the system was approved for use in the U.S. by the FDA in the the right atrium of the heart. With 2001 sales of $22.9 million, Endocardial Solutions now has a presence in 25 countries worldwide. Endocardial Solutions' shares are traded on NASDAQ under the symbol ECSI.

Fourth Quarter and 2003 Earnings Results
January 27, 2004

Endocardial Solutions, Inc. (Nasdaq: ECSI) invites you to participate in a teleconference call to discuss the Fourth Quarter and 2003 Earnings Results on January 27, 2004 at 9:30am (Central Time). Jim Bullock, President and CEO, will lead the call. Please call the number listed below five minutes prior to the call. We look forward to your participation. Instant replay of this call will be available two hours after the call has ended until 12:00 midnight (CST) on February 10, 2004. The teleconference will be webcast simultaneously through Endocardialís website at and at

Call-In Information
Endocardial Solutions, Inc.
Fourth Quarter and 2003 Earnings Conference Call
January 27, 2004
9:30am (Central Time)
US/Canada Participants: 877-272-5391
International Participants: 706-634-0654
Moderator: Jim Bullock

Instant Replay through February 10, 2004
US/Canada participants: 800-642-1687
International Participants: 706-645-9291
Conference ID: 11120

About ESI

Contact Us